TIPSLIFEHACKS

Trump's FDA Cuts: Experts Warn of Delays in New Medicine Approvals

STAT

The latest Trump orders have sparked concerns among public health experts, who fear the FDA workforce will be significantly reduced, hindering the agency's ability to review and approve new medicines. This could have serious implications for the healthcare industry, with potential delays in the development of life-saving treatments. As AI startups continue to emerge, overstating their capabilities, the need for stringent FDA oversight has never been more crucial. With the rise of digital health and medical technology, it's essential to ensure that new medicines are thoroughly vetted for safety and efficacy. Public health, healthcare industry, and FDA regulations are all at stake.